The intravenous immunoglobulin market size is projected to grow from USD 12.27 Billion in 2024 to USD 22.88 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.90% during the forecast period (2024 - 2032).
The Intravenous Immunoglobulin (IVIG) market is witnessing significant growth as a crucial component in the treatment of various autoimmune and immunodeficiency...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian